Direct brain infusion trial offers new hope for kids with relapsed glioma

This study tests whether giving two drugs (cetuximab and bevacizumab) directly into the brain's blood vessels each month is safe and can shrink tumors or slow their growth. It includes children and young adults under 22 with certain types of brain tumors that have come back or not responded to standard treatment. The goal is to control the disease, not cure it, and participants will be closely monitored for side effects and tumor response.